Perspective Therapeutics, Inc.
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.76 USD | +1.15% | -4.35% | +337.81% |
01:52pm | RBC Starts Perspective Therapeutics With Outperform Rating, $3 Price Target | MT |
May. 09 | Cantor Fitzgerald Starts Perspective Therapeutics With Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+337.81% | 1.02B | |
-5.51% | 182B | |
+2.33% | 111B | |
-3.62% | 68.48B | |
+1.52% | 49.69B | |
+8.06% | 44.46B | |
+2.33% | 40.67B | |
+23.35% | 31.22B | |
+0.67% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- CATX Stock
- News Perspective Therapeutics, Inc.
- Transcript : Isoray, Inc., Viewpoint Molecular Targeting, Inc., IsoRay Medical, Inc. - Special Call